| Viibryd (vilazodone) / AbbVie |
NCT00290914: Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder |
|
|
| Completed | 2 | | US | Vilazodone | Pharmacology Research Institute | Major Depressive Disorder | | | | |
NCT01828515: Vilazodone for Corticosteroid-Induced Memory Impairment |
|
|
| Completed | 2 | 24 | US | Vilazodone, Viibryd, Placebo, Hydrocortisone | University of Texas Southwestern Medical Center, Forest Laboratories | Memory Impairment | 04/14 | 04/14 | | |
| Completed | 2 | 76 | US | Vilazodone, Viibryd, Placebo | Medical University of South Carolina, National Institute on Drug Abuse (NIDA) | Marijuana Dependence | 08/15 | 02/16 | | |
NCT01742832: Double-Blind Treatment of Major Depressive Disorder With Vilazodone |
|
|
| Completed | 2 | 79 | US | Vilazodone, Citalopram | University of Chicago | Major Depressive Disorder | 03/16 | 03/16 | | |
NCT05422612: Department of Defense PTSD Adaptive Platform Trial - Master Protocol |
|
|
| Recruiting | 2 | 800 | US | Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo, Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo, Intervention C Daridorexant, Intervention C Placebo, Intervention D SLS-002, Intervention D Placebo | Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD Development, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline | Post Traumatic Stress Disorder | 03/26 | 09/26 | | |
NCT05948579: Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone |
|
|
| Not yet recruiting | 2 | 200 | NA | Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo | Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD Development, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline | Post Traumatic Stress Disorder | 03/26 | 09/26 | | |
